Device Cardiac

Matracell Pulmonary Patch Graft

Payments companies reported to CMS as associated with Matracell Pulmonary Patch Graft. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$14Kassociated payments (2023-2025)
20clinicians with associated payments
2companies reporting

By year

2023 $1,455
2024 $379
2025 $12K

Payments reported as associated with Matracell Pulmonary Patch Graft, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Surgery $9,530
Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,190
Vascular Surgery $476
Surgical Critical Care $104
Undersea and Hyperbaric Medicine (Emergency Medicine) $79.47
Nurse Practitioner $45.08

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Matracell Pulmonary Patch Graft

These are the largest totals companies reported as associated with Matracell Pulmonary Patch Graft. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Joseph Turek Chapel Hill, NC Surgery $9,426.57
Joseph Forbess Baltimore, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,600.00
Gary Raff Sacramento, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,000.00
Thomas Maxey Charlotte, NC Thoracic Surgery (Cardiothoracic Vascular Surgery) $400.00
William Gray Los Angeles, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $151.96
John Ross Orangeburg, SC Vascular Surgery $147.50
Meena Archie Orange, CA Vascular Surgery $132.50
Cabrini Sutherland Matthews, NC Surgical Critical Care $103.75
Iyore James Matthews, NC Surgery $103.74
Marc Mancinelli Erie, PA Undersea and Hyperbaric Medicine (Emergency Medicine) $79.47

Prescribed Matracell Pulmonary Patch Graft?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.